Bioactive and degradable porous bioceramics play an important role in many clinical situations. Porosity is essential to the performance of a material that is proposed to be used as an implantable osseous scaffold. Scaffolds provide a three dimensional support and template to osseous integration and vascularization. Combining the porosity of a scaffold with the ability of the scaffold material to deliver therapeutic ions to the site of implantation goes some way towards developing an ideal bone graft. A series of strontium-doped zinc silicate (Ca-Sr-Na-Zn-Si) glass ceramics scaffoldswere developed, whose porosity was measured to be between 93% and 96%, which is advantageous in terms of osseous integration and vascularization. The levels of Zn2+ and Sr2+ detected as a result of degradation of the crystalline phases were found to be 1.4–600 parts per million (ppm) and 0–583 ppm, respectively. The levels detected correlate well with the levels of Sr2+ and Zn2+ions typically associated with clinical benefits, including antibacterial efficacy, osteoblastic differentiation and impaired osteoclastic resorption.
RussellJLBlockJE. Surgical harvesting of bone graft from the ilium: Point of view. Med Hypotheses2000; 55: 474–479.
2.
Vitale-BrovaroneCVernéERobiglioLAppendinoPBassiFMartinassoGMuzioG. Development of glass-ceramic scaffolds for bone tissue engineering: Characterisation, proliferation of human osteoblasts and nodule formation. Acta Biomater2007; 3: 199–208.
3.
CarsonJSBostromMP. Synthetic bone scaffolds and fracture repair. Injury2007; 38(1): S33–S37.
4.
BanwartJCAsherMAHassaneinRS. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine (Phila Pa 1976)1995; 20: 1055–1060.
5.
KeatingJFMcQueenMM. Substitutes for autologous bone graft in orthopaedic trauma. J Bone Joint Surg Br2001; 83: 3–8.
6.
SimondsRJHolmbergSDHurwitzRLColemanTRBottenfieldSConleyLJ. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med1992; 326: 726–732.
7.
MurphySBoydDMoaneSBennettM. The effect of composition on ion release from Ca-Sr-Na-Zn-Si glass bone grafts. J Mater Sci Mater Med2009; E-pub ahead of print, DOI: 10.1007/s10856-009-3789-y.
8.
JarchoMKayJFGumaerKIDoremusRHDrobeckHP. Tissue, cellular and subcellular events at a bone-ceramic hydroxylapatite interface. J Bioeng1977; 1: 79–92.
9.
NagaseMChenRBArayaYNakajimaT. Evaluation of a bone substitute prepared from alpha-tricalcium phosphate and an acid polysaccharide solution. J Oral Maxillofac Surg1991; 49: 1305–1309.
10.
DaculsiGLeGerosRZHeughebaertMBarbieuxI. Formation of carbonate-apatite crystals after implantation of calcium phosphate ceramics. Calcif Tissue Int1990; 46: 20–27.
11.
KokuboTSMNagashimaYTashiroMNakamuraTYamamuroTHigashiS. Apatite and wollastonite-containing glass-ceramics for prosthetic application. Bull Inst Chem Res Kyoto Univ1982; 60: 260–268.
12.
El-GhannamANingCQMehtaJ. Cyclosilicate nanocomposite: A novel resorbable bioactive tissue engineering scaffold for BMP and bone-marrow cell delivery. J Biomed Mater Res A2004; 71: 377–390.
13.
WalshWRVizesiFMichaelDAuldJLangdownAOliverR. Beta-TCP bone graft substitutes in a bilateral rabbit tibial defect model. Biomaterials2008; 29: 266–271.
14.
McAuliffeJA. Bone graft substitutes. J Hand Ther2003; 16: 180–187.
15.
Vitale-BrovaroneCMiolaMBalagnaCVernéE. 3D-glass-ceramic scaffolds with antibacterial properties for bone grafting. Chem Eng J2008; 137: 129–136.
16.
ChenQZThompsonIDBoccacciniAR. Bioglass-derived glass-ceramic scaffolds for bone tissue engineering. Biomaterials2006; 27: 2414–2425.
17.
BainoFVernéEVitale-BrovaroneC. 3-D high-strength glass-ceramic scaffolds containing fluoroapatite for load-bearing bone portions replacement. Mat Sci Eng C2011.
18.
CampocciaDMontanaroLArciolaCR. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials2006; 27: 2331–2339.
19.
SeebachCSchultheissJWilhelmKFrankJHenrichD. Comparison of six bone-graft substitutes regarding to cell seeding efficiency, metabolism and growth behaviour of human mesenchymal stem cells (MSC) in vitro. Injury2010; 41: 731–738.
20.
LinKChangJZengYQianW. Preparation of macroporous calcium silicate ceramics. Mater Lett2004; 58: 2109–2113.
21.
HingKA. Bioceramic bone graft substitutes: Influence of porosity and chemistry. Int J Appl Ceramic Technol2005; 2: 184–199.
22.
XynosIDHukkanenMVBattenJJButteryLDHenchLLPolakJM. Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation In vitro: Implications and applications for bone tissue engineering. Calcif Tissue Int2000; 67: 321–329.
23.
AllanINewmanHWilsonM. Antibacterial activity of particulate bioglass against supra- and subgingival bacteria. Biomaterials2001; 22: 1683–1687.
24.
MatsumotoNSatoKYoshidaKHashimotoKTodaY. Preparation and characterization of beta-tricalcium phosphate co-doped with monovalent and divalent antibacterial metal ions. Acta Biomater2009; 5: 3157–3164.
25.
ChaiFHornezJCBlanchemainNNeutCDescampsMHildebrandHF. Antibacterial activation of hydroxyapatite (HA) with controlled porosity by different antibiotics. Biomol Eng2007; 24: 510–514.
26.
MartinaMSubramanyamGWeaverJCHutmacherDWMorseDEValiyaveettilS. Developing macroporous bicontinuous materials as scaffolds for tissue engineering. Biomaterials2005; 26: 5609–5616.
27.
LiBLiuXCaoCMengFDongYCuiT. Preparation and antibacterial effect of plasma sprayed wollastonite coatings loading silver. Appl Surf Sci2008; 255: 452–454.
BoydDLiHTannerDATowlerMRWallJG. The antibacterial effects of zinc ion migration from zinc-based glass polyalkenoate cements. J Mater Sci Mater Med2006; 17: 489–494.
30.
BoydDCarrollGTowlerMRFreemanCFarthingPBrookIM. Preliminary investigation of novel bone graft substitutes based on strontium-calcium-zinc-silicate glasses. J Mater Sci Mater Med2009; 20: 413–420.
31.
BoydDMurphySTowlerMRWrenAWHayakawaS. Analysis of gamma-irradiated synthetic bone grafts by Si-29 MAS-NMR spectroscopy, calorimetry and XRD. J Non-Cryst Solids2009; 355: 2285–2288.
32.
BoydDTowlerMRWattsSHillRGWrenAWClarkinOM. The role of Sr2+ on the structure and reactivity of SrO-CaO-ZnO-SiO2 ionomer glasses. J Mater Sci Mater Med2008; 19: 953–957.
33.
PoppJRLoveBJGoldsteinAS. Effect of soluble zinc on differentiation of osteoprogenitor cells. J Biomed Mater Res A2007; 81: 766–769.
34.
ChenDWaiteLCPierceWM. In vitro effects of zinc on markers of bone formation. Biol Trace Elem Res1999; 68: 225–234.
35.
ItoAKawamuraHOtsukaMIkeuchiMOhgushiHIshikawaK. Zinc-releasing calcium phosphate for stimulating bone formation. Mater Sci Eng C2002; 22: 21–25.
36.
CapucciniCTorricelliPSimaFBoaniniERistoscuCBracciB. Strontium-substituted hydroxyapatite coatings synthesized by pulsed-laser deposition: In vitro osteoblast and osteoclast response. Acta Biomater2008; 4: 1885–1893.
37.
ZhuLLZaidiSPengYZhouHMoongaBSBlesiusA. Induction of a program gene expression during osteoblast differentiation with strontium ranelate. Biochem Biophys Res Commun2007; 355: 307–311.
38.
BonnelyeEChabadelASaltelFJurdicP. Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone2008; 42: 129–138.
39.
YamaguchiMIgarashiAUchiyamaS. Bioavailability of zinc yeast in rats: Stimulatory effect on bone calcification in vivo. J Health Sci2004; 50: 75–81.
40.
LooneyMO'SheaHRedingtonWKellyGBoydD. High-temperature X-ray analysis of phase evolution in Sr-doped zinc-silicate glasses. J Non Cryst Solids2011; 357: 2097–2102.
41.
Biological evaluation of medical devices. In Identification and quantification of degradation products from ceramics. Geneva: International Organization of Standardization, 1997, Part 14.
42.
WakaiFYoshidaMShinodaYAkatsuT. Coarsening and grain growth in sintering of two particles of different sizes. Acta Mater2005; 53: 1361–1371.
43.
DiasAGGibsonIRSantosJDLopesMA. Physicochemical degradation studies of calcium phosphate glass ceramic in the CaO-P2O5-MgO-TiO2 system. Acta Biomater2007; 3: 263–269.
44.
SalamaSNSalmanSM. Characterization of glass-ceramic corrosion and durability. J Eur Ceram Soc1994; 13: 521–528.
45.
ClarkDEZoitosBK. Corrosion of glass, ceramics and ceramic superconductors: Principles, testing, characterization and applications, Park Ridge, NJ: Noyes Publications, 1992.
46.
HenchLLClarkDELue Yen-BowerE. Corrosion of glasses and glass-ceramics. Nucl Chem Waste Man1980; 1: 59–75.
47.
Zreiqat H, Yogambha Ramaswamy, Chengtie Wu, Angelo Paschalidis, ZuFu Lu, Barbara James, et al. The incorporation of strontium and zinc into a calcium-silicon ceramic for bone tissue engineering. Biomaterials, in press.
48.
MiaoSChengKWengWDuPShenGHanG. Fabrication and evaluation of Zn containing fluoridated hydroxyapatite layer with Zn release ability. Acta Biomater2008; 4: 441–446.
49.
RamaswamyYWuCZhouHZreiqatH. Biological response of human bone cells to zinc-modifiedCa-Si-based ceramics. Acta Biomater2008; 4: 1487–1497.
50.
BandyopadhyayAWitheyEAMooreJBoseS. Influence of ZnO doping in calcium phosphate ceramics. Mat Sci Eng C-Bio S2007; 27: 14–17.
51.
ColemanNJBishopAHBoothSENicholsonJW. Ag+- and Zn2+-exchange kinetics and antimicrobial properties of 11 Å tobermorites. J Eur Ceram Soc2009; 29: 1109–1117.
WuCRamaswamyYKwikDZreiqatH. The effect of strontium incorporation into CaSiO3 ceramics on their physical and biological properties. Biomaterials2007; 28: 3171–3181.
55.
Pors NielsenS. The biological role of strontium. Bone2004; 35: 583–588.
